These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23526298)

  • 21. New evidence for nicotinic acid treatment to reduce atherosclerosis.
    Montecucco F; Quercioli A; Dallegri F; Viviani GL; Mach F
    Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1457-67. PubMed ID: 20936932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.
    Singh N; Gurav A; Sivaprakasam S; Brady E; Padia R; Shi H; Thangaraju M; Prasad PD; Manicassamy S; Munn DH; Lee JR; Offermanns S; Ganapathy V
    Immunity; 2014 Jan; 40(1):128-39. PubMed ID: 24412617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Niacin stimulates adiponectin secretion through the GPR109A receptor.
    Plaisance EP; Lukasova M; Offermanns S; Zhang Y; Cao G; Judd RL
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E549-58. PubMed ID: 19141678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Niacin Ameliorates Neuro-Inflammation in Parkinson's Disease via GPR109A.
    Giri B; Belanger K; Seamon M; Bradley E; Purohit S; Chong R; Morgan JC; Baban B; Wakade C
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets.
    Chen L; So WY; Li SY; Cheng Q; Boucher BJ; Leung PS
    Mol Cell Endocrinol; 2015 Mar; 404():56-66. PubMed ID: 25622782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Internalization of the human nicotinic acid receptor GPR109A is regulated by G(i), GRK2, and arrestin3.
    Li G; Shi Y; Huang H; Zhang Y; Wu K; Luo J; Sun Y; Lu J; Benovic JL; Zhou N
    J Biol Chem; 2010 Jul; 285(29):22605-18. PubMed ID: 20460384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Niacin: an old drug rejuvenated.
    Kamanna VS; Ganji SH; Kashyap ML
    Curr Atheroscler Rep; 2009 Jan; 11(1):45-51. PubMed ID: 19080727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2.
    Graff EC; Fang H; Wanders D; Judd RL
    Metabolism; 2016 Feb; 65(2):102-13. PubMed ID: 26773933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicotinic acid: pharmacological effects and mechanisms of action.
    Gille A; Bodor ET; Ahmed K; Offermanns S
    Annu Rev Pharmacol Toxicol; 2008; 48():79-106. PubMed ID: 17705685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Niacin in cardiovascular disease: recent preclinical and clinical developments.
    Digby JE; Ruparelia N; Choudhury RP
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):582-8. PubMed ID: 22207729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Niacin: the evidence, clinical use, and future directions.
    Villines TC; Kim AS; Gore RS; Taylor AJ
    Curr Atheroscler Rep; 2012 Feb; 14(1):49-59. PubMed ID: 22037771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nicotinic acid: recent developments.
    Kamanna VS; Vo A; Kashyap ML
    Curr Opin Cardiol; 2008 Jul; 23(4):393-8. PubMed ID: 18520725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct kinetic and spatial patterns of protein kinase C (PKC)- and epidermal growth factor receptor (EGFR)-dependent activation of extracellular signal-regulated kinases 1 and 2 by human nicotinic acid receptor GPR109A.
    Li G; Deng X; Wu C; Zhou Q; Chen L; Shi Y; Huang H; Zhou N
    J Biol Chem; 2011 Sep; 286(36):31199-212. PubMed ID: 21768093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice.
    Hanson J; Gille A; Zwykiel S; Lukasova M; Clausen BE; Ahmed K; Tunaru S; Wirth A; Offermanns S
    J Clin Invest; 2010 Aug; 120(8):2910-9. PubMed ID: 20664170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel treatment target for Parkinson's disease.
    Wakade C; Chong R
    J Neurol Sci; 2014 Dec; 347(1-2):34-8. PubMed ID: 25455298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms.
    Digby JE; Martinez F; Jefferson A; Ruparelia N; Chai J; Wamil M; Greaves DR; Choudhury RP
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):669-76. PubMed ID: 22267479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target.
    Offermanns S
    Trends Pharmacol Sci; 2006 Jul; 27(7):384-90. PubMed ID: 16766048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy.
    Gambhir D; Ananth S; Veeranan-Karmegam R; Elangovan S; Hester S; Jennings E; Offermanns S; Nussbaum JJ; Smith SB; Thangaraju M; Ganapathy V; Martin PM
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2208-17. PubMed ID: 22427566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hypophagic response to heat stress is not mediated by GPR109A or peripheral β-OH butyrate.
    Hepler C; Foy CE; Higgins MR; Renquist BJ
    Am J Physiol Regul Integr Comp Physiol; 2016 May; 310(10):R992-8. PubMed ID: 26936786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon.
    Thangaraju M; Cresci GA; Liu K; Ananth S; Gnanaprakasam JP; Browning DD; Mellinger JD; Smith SB; Digby GJ; Lambert NA; Prasad PD; Ganapathy V
    Cancer Res; 2009 Apr; 69(7):2826-32. PubMed ID: 19276343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.